SXTP | tickerfilter.com

Fundamental analysis

42%

Profitability 35%

Dept financing 43%

Liquidity 75%

Performance 40%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-25.33%

1 Month

-41.04%

3 Months

133.20%

6 Months

60.99%

1 Year

40.12%

2 Year

644.26%

Key data

Stock price

$2.27

P/E Ratio

0.00

DAY RANGE

$2.26 - $2.42

EPS

-$15.75

52 WEEK RANGE

$0.34 - $8.62

52 WEEK CHANGE

$42.77

MARKET CAP

5.440 M

YIELD

N/A

SHARES OUTSTANDING

4.230 M

DIVIDEND

$0.00

EX-DIVIDEND DATE

02-24-2025

NEXT EARNINGS DATE

05-14-2025

BETA

3.46

PUBLIC FLOAT

AVERAGE 10 VOLUME

$36,105

AVERAGE 30 VOLUME

$58,959

Company detail

CEO: Geoffrey Dow
Region: US
Website: 60degreespharma.com
Employees: 0
IPO year: 2023

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are a growth-oriented specialty pharmaceutical company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. Our principal executive offices are located at 1025 Connecticut Avenue NW Suite 1000, Washington, D.C.

SXTP - 60 DEGREES PHARMACEUTICALS, INC.